𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An empirical comparison of EQ-5D and SF-6D in liver transplant patients

✍ Scribed by Louise Longworth; Stirling Bryan

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
151 KB
Volume
12
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

There remains disagreement about the preferred utility‐based measure of health‐related quality of life for use in constructing quality‐adjusted life years (QALYs). The recent development of a new measure, the SF‐6D, has highlighted this issue. The SF‐6D and EuroQol EQ‐5D measure health‐related utilities on a scale where 0 represents death and 1 represents full health, and both have utility scores generated from random samples of the general UK population. This study explored whether, in a large sample of liver transplant patients, the two instruments provide similar results. The empirical data highlight important variation in the results generated from the use of the two instruments. The data are consistent with a view that the SF‐6D does not describe health states at the lower end of the utility scale but is more sensitive than EQ‐5D in detecting small changes towards the top of the scale. Copyright © 2003 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Comparison of EQ-5D and SF-6D utilities
Comparison of EQ-5D and SF-6D utilities in mental health patients
✍ L. M. Lamers; C. A. M. Bouwmans; A. van Straten; M. C. H. Donker; L. Hakkaart 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Various preference-based measures of health are available for use as an outcome measure in cost-utility analysis. The aim of this study is to compare two such measures EQ-5D and SF-6D in mental health patients. Baseline data from a Dutch multi-centre randomised trial of 616 patients with mood and/or

A comparison of the EQ-5D and SF-6D acro
A comparison of the EQ-5D and SF-6D across seven patient groups
✍ John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

## Abstract As the number of preference‐based instruments grows, it becomes increasingly important to compare different preference‐based measures of health in order to inform an important debate on the choice of instrument. This paper presents a comparison of two of them, the EQ‐5D and the SF‐6D (r

A comparison of the performance of the E
A comparison of the performance of the EQ-5D and SF-6D for individuals aged ≥ 45 years
✍ Garry R. Barton; Tracey H. Sach; Anthony J. Avery; Claire Jenkinson; Michael Doh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

## Abstract We sought to compare the performance of the EQ‐5D and SF‐6D with regard to the criteria of practicality, convergent validity, and construct validity, the level of agreement between the two measures was also assessed. Responses from 1865 individuals aged ≥ 45 years in one general practic

The validity of EQ-5D US preference weig
The validity of EQ-5D US preference weights in liver transplant candidates and recipients
✍ Robert T. Russell; Irene D. Feurer; Panarut Wisawatapnimit; C. Wright Pinson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Health utility instruments assess patients' valuation of specific health states, which can be converted to quality-adjusted life years for cost-utility analysis. Data from the EQ-5D, a generic health-related quality of life questionnaire from EuroQoL, can be reported as 5 health status scores or as

Immunogenicity and safety of an experime
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients
✍ Frederik Nevens; Jane N. Zuckerman; Andrew K. Burroughs; Maria-Christina Jung; J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Patients with chronic liver disease are at higher risk of hepatitis B (HB) virus infection before and after liver transplantation, and they commonly have a suboptimal immune response to HB vaccines. In this randomized trial, we compared the immunogenicity of primary vaccination with 2 doses of an ex